Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360° synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of eye disorders
3.2.1.2 Technological advancements in ophthalmic drug delivery systems
3.2.1.3 Increasing geriatric population coupled with disease
3.2.1.4 Increasing awareness and diagnosis
3.2.2 Industry pitfalls & challenges
3.2.2.1 Non-compliance and poor adherence
3.2.2.2 Associated side effects and tolerance issues
3.3 Growth potential analysis
3.4 Volume analysis of preservative-free multi-dose eye dropper, 2018-2032
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Eye Dropper Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Unidose eye dropper
5.3 Preserved multi-dose eye dropper
5.4 Preservative-free multi-dose eye dropper
Chapter 6 Market Estimates and Forecast, By Mode, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Prescription drugs
6.3 Over the counter (OTC) drugs
Chapter 7 Market Estimates and Forecast, By Indication, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Glaucoma
7.3 Allergies
7.4 Conjunctivitis
7.5 Dry eye
7.6 Other indications
Chapter 8 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Ophthalmic clinics
8.4 Homecare settings
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 AbbVie Inc.
10.2 Alcon Inc.
10.3 AdvaCare Pharma
10.4 Bausch Health Companies Inc.
10.5 Dompé Farmaceutici S.p.A
10.6 Novartis AG
10.7 Pfizer Inc.
10.8 PanOptica, Inc.
10.9 Prestige Consumer Healthcare Inc.
10.10 Sun Pharmaceutical Industries Ltd.
